nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CYP2C9—Methimazole—Graves' disease	0.193	1	CbGbCtD
Ketoprofen—Aplastic anaemia—Methimazole—Graves' disease	0.0353	0.06	CcSEcCtD
Ketoprofen—Aplastic anaemia—Propylthiouracil—Graves' disease	0.03	0.051	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0246	0.0418	CcSEcCtD
Ketoprofen—Drowsiness—Methimazole—Graves' disease	0.021	0.0357	CcSEcCtD
Ketoprofen—Jaundice—Methimazole—Graves' disease	0.0205	0.0348	CcSEcCtD
Ketoprofen—Agranulocytosis—Methimazole—Graves' disease	0.0196	0.0334	CcSEcCtD
Ketoprofen—Hepatitis—Methimazole—Graves' disease	0.0189	0.0321	CcSEcCtD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.0184	0.0844	CbGpPWpGaD
Ketoprofen—Drowsiness—Propylthiouracil—Graves' disease	0.0179	0.0304	CcSEcCtD
Ketoprofen—Jaundice—Propylthiouracil—Graves' disease	0.0174	0.0296	CcSEcCtD
Ketoprofen—Agranulocytosis—Propylthiouracil—Graves' disease	0.0167	0.0284	CcSEcCtD
Ketoprofen—Alopecia—Methimazole—Graves' disease	0.0167	0.0284	CcSEcCtD
Ketoprofen—Hepatitis—Propylthiouracil—Graves' disease	0.0161	0.0273	CcSEcCtD
Ketoprofen—Vertigo—Methimazole—Graves' disease	0.0148	0.0251	CcSEcCtD
Ketoprofen—Alopecia—Propylthiouracil—Graves' disease	0.0142	0.0241	CcSEcCtD
Ketoprofen—Myalgia—Methimazole—Graves' disease	0.014	0.0238	CcSEcCtD
Ketoprofen—Dysgeusia—Propylthiouracil—Graves' disease	0.0137	0.0233	CcSEcCtD
Ketoprofen—Oedema—Methimazole—Graves' disease	0.0134	0.0228	CcSEcCtD
Ketoprofen—Thrombocytopenia—Methimazole—Graves' disease	0.0131	0.0223	CcSEcCtD
Ketoprofen—Vertigo—Propylthiouracil—Graves' disease	0.0126	0.0213	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0122	0.0208	CcSEcCtD
Ketoprofen—Paraesthesia—Methimazole—Graves' disease	0.0121	0.0205	CcSEcCtD
Ketoprofen—Somnolence—Methimazole—Graves' disease	0.0119	0.0203	CcSEcCtD
Ketoprofen—Myalgia—Propylthiouracil—Graves' disease	0.0119	0.0202	CcSEcCtD
Ketoprofen—Dyspepsia—Methimazole—Graves' disease	0.0118	0.0201	CcSEcCtD
Ketoprofen—Oedema—Propylthiouracil—Graves' disease	0.0114	0.0194	CcSEcCtD
Ketoprofen—Thrombocytopenia—Propylthiouracil—Graves' disease	0.0112	0.019	CcSEcCtD
Ketoprofen—Urticaria—Methimazole—Graves' disease	0.0107	0.0181	CcSEcCtD
Ketoprofen—CXCR1—Peptide GPCRs—TSHR—Graves' disease	0.0106	0.0487	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0104	0.0177	CcSEcCtD
Ketoprofen—Paraesthesia—Propylthiouracil—Graves' disease	0.0102	0.0174	CcSEcCtD
Ketoprofen—Somnolence—Propylthiouracil—Graves' disease	0.0101	0.0172	CcSEcCtD
Ketoprofen—Dyspepsia—Propylthiouracil—Graves' disease	0.01	0.0171	CcSEcCtD
Ketoprofen—Pruritus—Methimazole—Graves' disease	0.0095	0.0161	CcSEcCtD
Ketoprofen—Urticaria—Propylthiouracil—Graves' disease	0.00907	0.0154	CcSEcCtD
Ketoprofen—CXCR1—Chemokine receptors bind chemokines—CXCL10—Graves' disease	0.00859	0.0394	CbGpPWpGaD
Ketoprofen—Vomiting—Methimazole—Graves' disease	0.00854	0.0145	CcSEcCtD
Ketoprofen—Rash—Methimazole—Graves' disease	0.00846	0.0144	CcSEcCtD
Ketoprofen—Dermatitis—Methimazole—Graves' disease	0.00846	0.0144	CcSEcCtD
Ketoprofen—Headache—Methimazole—Graves' disease	0.00841	0.0143	CcSEcCtD
Ketoprofen—Pruritus—Propylthiouracil—Graves' disease	0.00808	0.0137	CcSEcCtD
Ketoprofen—Nausea—Methimazole—Graves' disease	0.00797	0.0135	CcSEcCtD
Ketoprofen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.00737	0.0338	CbGpPWpGaD
Ketoprofen—Vomiting—Propylthiouracil—Graves' disease	0.00726	0.0123	CcSEcCtD
Ketoprofen—Rash—Propylthiouracil—Graves' disease	0.0072	0.0122	CcSEcCtD
Ketoprofen—Dermatitis—Propylthiouracil—Graves' disease	0.00719	0.0122	CcSEcCtD
Ketoprofen—Headache—Propylthiouracil—Graves' disease	0.00715	0.0121	CcSEcCtD
Ketoprofen—Nausea—Propylthiouracil—Graves' disease	0.00678	0.0115	CcSEcCtD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.00468	0.0214	CbGpPWpGaD
Ketoprofen—CXCL8—Chemokine receptors bind chemokines—CXCL10—Graves' disease	0.00388	0.0178	CbGpPWpGaD
Ketoprofen—CXCL8—TSLP Signaling Pathway—IL2RA—Graves' disease	0.00341	0.0156	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.00338	0.0155	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-E—Graves' disease	0.00337	0.0154	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00336	0.0154	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—CD40—Graves' disease	0.00329	0.0151	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—CTLA4—Graves' disease	0.00325	0.0149	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.00324	0.0149	CbGpPWpGaD
Ketoprofen—CXCR1—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.00323	0.0148	CbGpPWpGaD
Ketoprofen—CXCL8—Overview of nanoparticle effects—TNF—Graves' disease	0.003	0.0138	CbGpPWpGaD
Ketoprofen—CXCR1—G alpha (i) signalling events—CXCL10—Graves' disease	0.00273	0.0125	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.00269	0.0123	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-DQB1—Graves' disease	0.00267	0.0122	CbGpPWpGaD
Ketoprofen—CXCL8—EBV LMP1 signaling—TNF—Graves' disease	0.00258	0.0118	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—TSHR—Graves' disease	0.00256	0.0117	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—HLA-A—Graves' disease	0.00245	0.0112	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-B—Graves' disease	0.0024	0.011	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.0024	0.011	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—FASLG—Graves' disease	0.00235	0.0108	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.00229	0.0105	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—FAS—Graves' disease	0.00226	0.0104	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL2RA—Graves' disease	0.00225	0.0103	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-A—Graves' disease	0.00223	0.0102	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.0022	0.0101	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00217	0.00994	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.00214	0.00981	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—CXCL10—Graves' disease	0.00214	0.00979	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.0021	0.0096	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.00205	0.0094	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-DRB1—Graves' disease	0.00203	0.00931	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.00189	0.00868	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—IFNG—Graves' disease	0.00188	0.00859	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.00187	0.00858	CbGpPWpGaD
Ketoprofen—PTGS1—Overview of nanoparticle effects—TNF—Graves' disease	0.00166	0.0076	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CXCL10—Graves' disease	0.00165	0.00757	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—IFNG—Graves' disease	0.00164	0.00749	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00151	0.00694	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IFNG—Graves' disease	0.00148	0.0068	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.00148	0.00679	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.00146	0.00669	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.00145	0.00664	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—TSHR—Graves' disease	0.00144	0.00662	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.00144	0.0066	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.00142	0.00651	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00142	0.00649	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—ICAM1—Graves' disease	0.00142	0.00648	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.00139	0.00635	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL1B—Graves' disease	0.00132	0.00607	CbGpPWpGaD
Ketoprofen—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.00132	0.00603	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—TSHR—Graves' disease	0.00131	0.00601	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00128	0.00589	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—CXCL10—Graves' disease	0.00123	0.00564	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.00118	0.00542	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—TSHR—Graves' disease	0.00115	0.00528	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00108	0.00497	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00108	0.00495	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.00108	0.00495	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IFNG—Graves' disease	0.00108	0.00493	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.00105	0.00483	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00104	0.00474	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000988	0.00453	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000981	0.0045	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—B3GNT2—Graves' disease	0.000979	0.00449	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000979	0.00448	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—TNF—Graves' disease	0.000961	0.0044	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL1B—Graves' disease	0.000961	0.0044	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000959	0.00439	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000938	0.0043	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.000936	0.00429	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—CXCL10—Graves' disease	0.000933	0.00428	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000901	0.00413	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CXCL10—Graves' disease	0.000847	0.00388	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000843	0.00386	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000825	0.00378	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—ICAM1—Graves' disease	0.000798	0.00366	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000784	0.00359	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000783	0.00359	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TSHR—Graves' disease	0.000775	0.00355	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000774	0.00355	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000768	0.00352	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IFNG—Graves' disease	0.000751	0.00344	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000747	0.00342	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CXCL10—Graves' disease	0.000745	0.00341	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—IL2RA—Graves' disease	0.000713	0.00327	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TNF—Graves' disease	0.000697	0.00319	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IL1B—Graves' disease	0.00067	0.00307	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000666	0.00305	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000655	0.003	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—TSHR—Graves' disease	0.000652	0.00299	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000649	0.00297	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—IL2RA—Graves' disease	0.000648	0.00297	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000634	0.00291	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	0.00062	0.00284	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000611	0.0028	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IFNG—Graves' disease	0.000608	0.00278	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000607	0.00278	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	0.000598	0.00274	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	0.000597	0.00273	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—TSHR—Graves' disease	0.000592	0.00271	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000558	0.00255	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IL1B—Graves' disease	0.000542	0.00248	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000533	0.00244	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	0.000532	0.00244	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00053	0.00243	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000507	0.00232	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CXCL10—Graves' disease	0.000501	0.00229	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000489	0.00224	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—TNF—Graves' disease	0.000486	0.00223	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	0.000483	0.00221	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GC—Graves' disease	0.000483	0.00221	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	0.000483	0.00221	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	0.000472	0.00216	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000468	0.00215	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000434	0.00199	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	0.000431	0.00197	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CXCL10—Graves' disease	0.000421	0.00193	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	0.000421	0.00193	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IL2RA—Graves' disease	0.000399	0.00183	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TNF—Graves' disease	0.000393	0.0018	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	0.000386	0.00177	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL2RA—Graves' disease	0.000383	0.00175	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CXCL10—Graves' disease	0.000382	0.00175	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GC—Graves' disease	0.000367	0.00168	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—B3GNT2—Graves' disease	0.000366	0.00168	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00035	0.0016	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TSHR—Graves' disease	0.00035	0.0016	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—IL2RA—Graves' disease	0.000322	0.00147	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—TNF—Graves' disease	0.000312	0.00143	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TNF—Graves' disease	0.000305	0.0014	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL2RA—Graves' disease	0.000292	0.00134	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GC—Graves' disease	0.000292	0.00134	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—B3GNT2—Graves' disease	0.000278	0.00128	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—B3GNT2—Graves' disease	0.000264	0.00121	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GC—Graves' disease	0.000237	0.00109	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GC—Graves' disease	0.000236	0.00108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CXCL10—Graves' disease	0.000226	0.00104	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—B3GNT2—Graves' disease	0.000221	0.00101	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000208	0.000952	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GC—Graves' disease	0.000193	0.000885	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2RA—Graves' disease	0.000181	0.000827	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—B3GNT2—Graves' disease	0.00018	0.000824	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—B3GNT2—Graves' disease	0.000179	0.000819	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2RA—Graves' disease	0.000173	0.000791	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—B3GNT2—Graves' disease	0.000146	0.000671	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HLA-A—Graves' disease	0.000107	0.000489	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD4—Graves' disease	6.88e-05	0.000315	CbGpPWpGaD
